Stratos Wealth Advisors, LLC Biomarin Pharmaceutical Inc Transaction History
Stratos Wealth Advisors, LLC
- $1.82 Billion
- Q2 2025
A detailed history of Stratos Wealth Advisors, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Stratos Wealth Advisors, LLC holds 35,268 shares of BMRN stock, worth $1.91 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
35,268
Previous 35,668
1.12%
Holding current value
$1.91 Million
Previous $2.52 Million
23.13%
% of portfolio
0.11%
Previous 0.14%
Shares
8 transactions
Others Institutions Holding BMRN
# of Institutions
675Shares Held
185MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.23 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.03 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$853 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$817 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$665 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.1B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...